Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
about
Two-way communication between the metabolic and cell cycle machineries: the molecular basisStructure-function analyses of the human SIX1–EYA2 complex reveal insights into metastasis and BOR syndromeThe DACH/EYA/SIX gene network and its role in tumor initiation and progressionThe EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromaroneStructure-activity relationships of benzbromarone metabolites and derivatives as EYA inhibitory anti-angiogenic agentsAllosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cellsMAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.MAPK target sites of eyes absent are not required for eye development or survival in DrosophilaEyes absent tyrosine phosphatase activity is not required for Drosophila development or survivalEya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferationGene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancerThe Eyes Absent proteins in development and disease.The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition.Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.Human HAD phosphatases: structure, mechanism, and roles in health and disease.The EYA-SO/SIX complex in development and disease.Atypical protein phosphatases: emerging players in cellular signaling.EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markersDACH1 Expresison in Osteosarcoma and Its Relationship with Proliferation and Angiogenesis.EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN.The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex.SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer.Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.The regulation of cytokine signaling by retinal determination gene network pathway in cancerEffect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
P2860
Q27013594-09F73E7E-E76F-4271-95B2-6DE766857506Q27676610-BDECFE5D-0D7E-4B19-872D-CED603784F14Q28263832-8F07A524-DADA-4791-8E5E-6ED6E16145DDQ28482486-2EBF948F-F629-4A99-8F59-EC6BE29D4D5EQ28537736-903598FE-8055-43A7-9B0A-C8BC74EE76F0Q30409822-74D31AE2-CF7A-4E2E-8578-240663A564CBQ33940667-FB8BC3CA-EA79-4235-B51F-7E36196E81CAQ34022861-7286100E-247B-422D-8718-F50812E53420Q34515858-D3852BCB-3AAC-4627-A0FD-DFD6F1500FBFQ34648361-8DD74D88-821A-433F-9C8A-48D8E92723DDQ35243673-230F3B7A-EA6C-4FD2-BDA5-BE807A0A715BQ35742423-AB909D10-4D94-4062-B2F0-5DEF71A3D5EEQ35924241-47A0F8F6-DB44-4E01-B7FB-01A58595A13DQ35926324-4FEEB346-C6A0-4E91-8F55-89573EEABBA8Q35944775-1FC2D2FE-91A8-40E9-BD5F-C537F140AD60Q36584002-0EFAF2FB-09A0-44E9-88A6-6DF5E29E21BEQ36597900-B5870324-AFF8-49D2-9F4F-35504DDC72CBQ36753726-08A47473-88FE-455A-8DD6-767533275900Q36757059-557755BA-7664-4C41-978A-2898E96C265DQ36917897-A592E0DB-1D20-4B6D-8A05-3DACE78DCD8AQ38011246-84E41EFB-A4EA-418C-87E4-6B66A4CCF14FQ38027074-68D02FD2-1E67-46FD-BA25-E9E381B4F14BQ38084832-224ED97A-E9DB-4EED-8531-4183ACA914C9Q38735111-CD808CC7-3962-4B55-B63F-F2B53A409F4EQ39888524-CCD36E69-3374-471A-9419-04E4A199B60AQ40993139-CF4A5218-E4B5-4CC8-A324-40BE6068489BQ41915510-DAC0ABD8-7285-4C2E-82D7-166704ECB832Q49497954-7E14A439-F998-45C9-A497-FD6B474330B8Q49788159-2AFDF50A-5FFC-4281-BACD-24633976245BQ50047509-BCC56BC9-8C13-49FB-8390-ACCBFE637C30Q53224484-5DC5200D-4CC4-4C2E-87DB-51264F76D5CDQ53414452-51933D5A-DE31-468C-8075-11332D6907C3Q54115875-233FC3E7-EB01-4A1D-B9FD-AF3A87D0E943Q57483942-607F96D7-97EE-4C99-9558-F99303AB3F2FQ59128608-D481F11E-8C3C-4D14-871A-26945A8A50F8
P2860
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@ast
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@en
type
label
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@ast
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@en
prefLabel
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@ast
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of Eyes Absent Homo ...... l nerve sheath tumor necrosis.
@en
P2093
A Hardiman
D M Patmore
J A Cancelas
J J Kordich
M H Collins
S J Miller
P2860
P2888
P304
P356
10.1038/ONC.2009.360
P407
P577
2009-11-09T00:00:00Z
P5875
P6179
1025920053